NuVasive Inc. (NUVA)

Business: NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery.

IPO Date: 13-May-2004

CEO & Director: Mr. J. Christopher Barry

Exec. VP & CFO: Mr. Matthew K. Harbaugh

Listing: NASDAQ: NUVA

Country: United States

Headquarters: San Diego, CA

Website: https://www.nuvasive.com

Market cap: $2,636.92 Mln

Revenue (TTM): $1,158.50 Mln

Earnings (TTM): $-37.38 Mln

Cash: $205.31 Mln

Total Debt: $1,005.93 Mln

Insider's Holding: 0.22%

Liquidity: Low

52 Week range: $45.45 - 70.00

Shares outstanding: 52,041,000

10 Years Aggregate:

• CFO: $1,589.63 Mln
• EBITDA: $1,386.10 Mln
• Net Profit: $157.24 Mln